OCGN Ocugen Inc

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

SCHEDULE 14A

 

Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

 

x	Filed by the Registrant
¨	Filed by a Party other than the Registrant
Check the appropriate box:
¨	Preliminary Proxy Statement
¨	Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
¨	Definitive Proxy Statement
x	Definitive Additional Materials
¨	Soliciting Material under §240.14a-12

 

OCUGEN, INC.
(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

 

 

Payment of Filing Fee (Check all boxes that apply):
x	No fee required
¨	Fee paid previously with preliminary materials
¨	Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11

 

 

 

 

 

May 13, 2022

 

Dear Stockholder:

 

We have previously sent you proxy material for the Annual Meeting of Ocugen, Inc. stockholders taking place on June 7, 2022. Your Board of Directors unanimously recommends that stockholders vote “FOR ALL” directors nominated for election to the Board and “FOR” the other two agenda items.

 

Your vote is important, no matter how many or how few shares you may own. If you have not already done so, please vote TODAY via the Internet, by telephone or by returning the enclosed proxy card in the postage-paid envelope provided.

 

Sincerely,

 

 

 

Shankar Musunuri

Chairman of the Board and Chief Executive Officer

 

REMEMBER:

You can vote your shares via the Internet or by telephone following the instructions set forth on the enclosed proxy card.

If you have any questions, or need assistance in voting

your shares, please call our proxy solicitor:

INNISFREE M&A INCORPORATED

TOLL-FREE, at 1-877-750-8315.